Prostatic Neoplasms: all 6,484 studies
Page 50 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid TumorsCompletedNCT02014337Phase 1
- A Study to Evaluate Oral VT-464 in Patients With Castration-Resistant Prostate CancerCompletedNCT02012920Phase 2
- Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate CancerCompletedNCT02008058
- A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate GlandCompletedNCT02004418Phase 1/2
- Early Investigation of High Precision Radiotherapy Prior to Commencing Standard Radiotherapy for Prostate CancerCompletedNCT02004223Not applicable
- Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone TherapyCompletedNCT02003417
- Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRICompletedNCT02002455Phase 2
- Intra-operative Trans-rectal Ultrasound Guidance for Robot-assisted Radical ProstatectomyCompletedNCT02001597
- A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic FunctionCompletedNCT02001571Phase 1
- Post-marketing Surveillance Regarding Efficacy and Safety of SpaceOAR™TerminatedNCT01999660
- Prothrombotic Factors and Anaesthesia in Prostate CancerCompletedNCT01998685Not applicable
- Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the ProstateTerminatedNCT01996696Phase 2
- 18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate CancerCompletedNCT01993160Not applicable
- Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate CancerCompletedNCT01992042Phase 2
- Intrathecal Morphine in Robot-assisted ProstatectomyCompletedNCT01991275Not applicable
- Prostate Screening Study Using MRI in BRCA CarriersActive, not recruitingNCT01990521Not applicable
- Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate CancerActive, not recruitingNCT01990196Phase 2
- Eradication of Prostate Cancer Using F-989CompletedNCT01987999Phase 2
- Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate CancerTerminatedNCT01983709Phase 1
- Intimacy-Enhancing Couples' Intervention for Localized Prostate CancerCompletedNCT01982058Not applicable
- The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen DeprivationWithdrawnNCT01981668Phase 1
- Efficacy Study Evaluating Chemotherapy in Prostate CancerStatus unknownNCT01978873Phase 3
- Functional MR-guided Stereotactic Body Radiation Therapy of Prostate CancerTerminatedNCT01976962Not applicable
- Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk PatientsStatus unknownNCT01972867Not applicable
- Metabolomic Study for Localized Prostate CancerStatus unknownNCT01968538
- Use of Multi-Parametric MRI With Prostate Biopsy for Cancer Diagnosis.CompletedNCT01964638Not applicable
- A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate CancerCompletedNCT01964170Phase 3
- Dose Escalation With SIB to Intraprostatic/Lymphatic GTV in High Risk Prostate CancerCompletedNCT01962324Not applicable
- Abiraterone Acetate for Castrate Resistant Prostate CancerCompletedNCT01961843Not applicable
- Evaluation of Diet and Exercise in Prostate Cancer PatientsCompletedNCT01960881
- A Phase III Study for Patients With Metastatic Hormone-naïve Prostate CancerActive, not recruitingNCT01957436Phase 3
- Brachytherapy for Recurrent Prostate CancerCompletedNCT01956058Phase 2
- Outpatient Radical Prostatectomy - Surgical and Anesthetic ConsiderationsCompletedNCT01955863Not applicable
- Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer PatientsCompletedNCT01954004
- Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition TherapyCompletedNCT01953640
- SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN)Status unknownNCT01953055Phase 1/2
- Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanningTerminatedNCT01950871Phase 4
- Effect of Sulforaphane on Prostate CAncer PrEventionCompletedNCT01950143Not applicable
- Docetaxel and Lycopene in Metastatic Prostate CancerCompletedNCT01949519Phase 1
- Sulforadex in Healthy Volunteers SADCompletedNCT01948362Phase 1
- Collection of Blood Specimens for Circulating Tumor Cell AnalysisCompletedNCT01943500
- A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic CancerTerminatedNCT01940237Not applicable
- Efficacy of Diclofenac Suppository for Pain Control in Ultrasound Guided Biopsy of ProstateCompletedNCT01939743Phase 2
- Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate CancerStatus unknownNCT01938339Not applicable
- Trial of Print Messages to Support the Role of Partners in Promoting Provider Discussions About Prostate Cancer Screening Among AA MenCompletedNCT01937585Not applicable
- Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR BrachytherapyActive, not recruitingNCT01936883Not applicable
- A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the DiseaseTerminatedNCT01933022Phase 4
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Use of Recombinant Adenovirus Therapy to Treat Localized Prostate CancerCompletedNCT01931046Phase 1/2
- 18F-NaF PET Imaging for Bone ScintigraphyCompletedNCT01930812Phase 3
- Japanese BAY88-8223 Monotherapy Phase II StudyCompletedNCT01929655Phase 2
- Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningSuspendedNCT01929239Phase 1/2
- Phase I/IIA Study of PET Imaging With 89Zr-Df-IAB2M in Metastatic Prostate CancerCompletedNCT01923727Phase 1/2
- Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing SurgeryActive, not recruitingNCT01923506Phase 1
- Hypofractionated Radiotherapy as Primary Therapy for Prostate CancerCompletedNCT01921803Phase 2
- Protection of Rectum From High Radiation Doses Using a SpacerTerminatedNCT01918605Not applicable
- Radiosensitizing and Radioprotectve Effects of Curcumin in Prostate CancerCompletedNCT01917890Not applicable
- Measurements Of Zinc Concentration On Specimens Taken During Trans-Perineal Prostate BiopsyCompletedNCT01915316
- Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant LesionActive, not recruitingNCT01913717Not applicable
- Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate BrachytherapyTerminatedNCT01913197Phase 1/2
- Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate CancerTerminatedNCT01913015Phase 1
- Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing SurgeryCompletedNCT01912820Phase 1
- A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male SubjectsCompletedNCT01911741Phase 1
- Drug-drug Interaction Study With MDV3100 and a Cocktail of SubstratesCompletedNCT01911728Phase 1
- Resistance Training and Protein Supplementation for Prostate Cancer SurvivorsCompletedNCT01909440Not applicable
- Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate BrachytherapyStatus unknownNCT01909388Phase 2
- A Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles In Patients With Castration-Resistant Prostate Cancer (MEL-CAP)TerminatedNCT01907009Phase 2/3
- Perioperative Changes of Cognitive Function According to Jugular Vein Insufficiency in Robot-assisted ProstatectomyCompletedNCT01905488
- Radiotherapy of the Prostate and the Pelvic Lymph Nodes After Neoadjuvant Antihormonal TreatmentCompletedNCT01903408Phase 2
- Effect of Cancer Nurse Navigators on Patient OutcomesTerminatedNCT01902823Phase 2/3
- Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.CompletedNCT01902680Phase 2
- Relative Bioavailability Study of Enzalutamide in Prostate Cancer PatientsCompletedNCT01902251Phase 1
- Periperal Blood Lymphocytes During Prostate RTWithdrawnNCT01899391
- Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate CancerCompletedNCT01897207Phase 1/2
- The Value of MultiSpectral 3 Tesla MRI in Active Surveillance of Prostate CancerCompletedNCT01896713Not applicable
- A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate CancerStatus unknownNCT01890096Phase 2
- Improving Energy Balance in Men With Prostate CancerCompletedNCT01886677Not applicable
- AZD8186 First Time In Patient Ascending Dose StudyCompletedNCT01884285Phase 1
- FOcal RECurrent Assessment and Salvage TreatmentStatus unknownNCT01883128Phase 2
- Prostate Delineation: High Quality Volume CTCompletedNCT01878773Not applicable
- Identifying Prostate Brachytherapy Seeds Using MRICompletedNCT01878058Not applicable
- Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate CancerCompletedNCT01875393Phase 3
- Shorter Duration Radiotherapy to Treat Prostate Cancer After Removal of the ProstateCompletedNCT01868386Phase 1/2
- Improved Prostate Cancer Diagnosis - Combination of Magnetic Resonance Imaging and BiomarkersCompletedNCT01864135Not applicable
- The Metformin Active Surveillance Trial (MAST) StudyActive, not recruitingNCT01864096Phase 3
- Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory TumoursCompletedNCT01861496Phase 1/2
- Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in ArgentinaCompletedNCT01861236
- Internal Radiation Therapy in Treating Patients With Low-Risk Prostate CancerWithdrawnNCT01859689Phase 2
- Soft Tissue Detection on MRI, Cone Beam CT and Fan Beam CT and Integration of Functional MRITerminatedNCT01859338
- Radiotherapy for Oligometastatic Prostate CancerCompletedNCT01859221Not applicable
- Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone AcetateCompletedNCT01858441Not applicable
- A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With AbirateroneCompletedNCT01857908
- Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate CancerTerminatedNCT01857817Phase 2
- Degarelix Before Radical ProstatectomyStatus unknownNCT01852864Early Phase 1
- Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard TreatmentActive, not recruitingNCT01851018Not applicable
- Socioeconomic Aspects Before and After Radiation Therapy in Patient With Prostate CancerStatus unknownNCT01849471
- Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care NetworksCompletedNCT01844999Not applicable
- The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility StudyStatus unknownNCT01842750Not applicable
- Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate CancerStatus unknownNCT01839994Phase 3
- Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided ManagementWithdrawnNCT01838265